Mr Mohammad Ismail
Higher Degree by Research Candidate
School of Pharmacy and Biomedical Sciences
College of Health
I'm a PhD candidate in the Prostate Cancer Research Group at SAHMRI, under the supervision of Dr. Zeyad Nassar and led by Professor Lisa Butler. My research centers on investigating the genetic landscape of prostate cancer, specifically targeting key metabolic pathways in prostate cancer. I'm deeply passionate about this endeavor and excited to contribute to our team's mission.
| Date | Position | Institution name |
|---|---|---|
| 2019 - 2022 | Research Assisstant | Cell Therapy Center, Amman |
| 2017 - 2018 | Medical Laboratory Technician | AL-Istiashari Hospita; |
| Language | Competency |
|---|---|
| Arabic | Can read, write, speak and understand spoken |
| English | Can read, write, speak and understand spoken |
| Date | Institution name | Country | Title |
|---|---|---|---|
| 2018 - 2021 | The University of Jordan | Jordan | Masters Degree |
| 2013 - 2017 | Hashemite University | Jordan | Bachelors Drgree |
| Year | Citation |
|---|---|
| 2025 | Hussein, S. A., Ababneh, N. A., Tarawneh, N., Ismail, M. A., Awidi, A., & Abdalla, S. (2025). Antitumor Effects of Quercetin and Luteolin in A375 Cutaneous Melanoma Cell Line Are Mediated by Upregulation of P-ERK, c-Myc, and the Upstream GPER. Life, 15(3), 21 pages. Scopus6 WoS8 Europe PMC6 |
| 2025 | Gharandouq, M. H., Ismail, M. A., Saleh, T., Zihlif, M., & Ababneh, N. A. (2025). Metformin Protects Human Induced Pluripotent Stem Cell (hiPSC)-Derived Neurons from Oxidative Damage Through Antioxidant Mechanisms. Neurotoxicity Research, 43(2), 17 pages. Scopus1 WoS1 Europe PMC1 |
| 2024 | Al-Asmar, A. A., Abuarqoub, D., Ababneh, N., Jafar, H., Zalloum, S., Ismail, M., . . . Awidi, A. (2024). Potential Effects of Photobiomodulation Therapy on Human Dental Pulp Stem Cells. APPLIED SCIENCES-BASEL, 14(1), 14 pages. WoS2 |
| 2024 | Abu-Humaidan, A. H. A., Ismail, M. A., Ahmad, F. M., Al Shboul, S., Barham, R., Tadros, J. S., . . . Saleh, T. (2024). Therapy-induced senescent cancer cells exhibit complement activation and increased complement regulatory protein expression. Immunology and Cell Biology, 102(4), 240-255. Scopus6 WoS8 Europe PMC7 |
| 2024 | Saleh, T., Naffa, R., Barakat, N. A., Ismail, M. A., Alotaibi, M. R., & Alsalem, M. (2024). Cisplatin Provokes Peripheral Nociception and Neuronal Features of Therapy-Induced Senescence and Calcium Dysregulation in Rats. Neurotoxicity Research, 42(1), 15 pages. Scopus7 WoS7 Europe PMC7 |
| 2023 | Alrabayah, M., Massad, I. M., Imraish, A., Jarrar, Y., Massad, F., Guzu, H., . . . Zihlif, M. (2023). Effects of <i>CYP2B6</i> Genetic Variants on the Propofol Dose and Response among Jordanian Arabic Patients Undergoing General Anesthesia. CURRENT DRUG METABOLISM, 23(14), 1156-1161. WoS1 Europe PMC1 |
| 2023 | El-Sadoni, M., Al Shboul, S., Alhesa, A., Shahin, N. A., Alsharaiah, E., Ismail, M. A., . . . Saleh, T. (2023). A three-marker signature identifies senescence in human breast cancer exposed to neoadjuvant chemotherapy. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 91(4), 345-360. WoS19 Europe PMC16 |
| 2023 | Asad, M. M., Abdelhafez, R. S., Barham, R., Abdaljaleel, M., Alkurdi, B., Al-Hadidi, S., . . . Ababneh, N. A. (2023). Three-dimensional cultures of gingival fibroblasts on fibrin-based scaffolds for gingival augmentation: A proof-of-concept study. ARCHIVES OF ORAL BIOLOGY, 154, 8 pages. WoS2 Europe PMC1 |
| 2023 | Abu-Humaidan, A., Ismail, M. A., Barham, R., Ahmad, F. M., Ababneh, N. A., & Saleh, T. (2023). Therapy induced senescence in cancer cell lines affects complement activation and complement regulatory proteins expression. IMMUNOBIOLOGY, 228(5), 93. |
| 2023 | Al Shboul, S., El-Sadoni, M., Alhesa, A., Abu Shahin, N., Abuquteish, D., Abu Al Karsaneh, O., . . . Saleh, T. (2023). NOXA expression is downregulated in human breast cancer undergoing incomplete pathological response and senescence after neoadjuvant chemotherapy. Scientific Reports, 13(1), 1-12. WoS14 Europe PMC10 |
| 2023 | Niemi, M. E. K., Karjalainen, J., Liao, R. G., Neale, B. M., Daly, M., Ganna, A., . . . Sedaghati-Khayat, B. (2023). Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x). Nature, 621(7977), E7-E26. Scopus63 WoS77 Europe PMC74 |
| 2022 | Ababneh, N. A., Barham, R., Al-Kurdi, B., Ali, D., Al Hadidi, S., Ismail, M. A., . . . Awidi, A. (2022). Generation of a human induced pluripotent stem cell (iPSC) line (JUCTCi019-A) from a patient with Charcot-Marie-Tooth disease type 2A2 (CMT2A2) due to a heterozygous missense substitution c.2119C > T (p. Arg707Trp) in MFN2 gene. STEM CELL RESEARCH, 62, 5 pages. WoS3 Europe PMC3 |
| 2021 | Sweidan, N., Esawi, E., Ismail, M., & Alshaer, W. (2021). Anticancer Cardenolides from the aerial parts of Calortopis procera. Zeitschrift Fur Naturforschung Section C Journal of Biosciences, 76(5), 243-250. Scopus4 WoS4 Europe PMC3 |
| 2020 | Odeh, F., Nsairat, H., Alshaer, W., Ismail, M. A., Esawi, E., Qaqish, B., . . . Ismail, S. I. (2020). Aptamers chemistry: Chemical modifications and conjugation strategies. Molecules, 25(1), 51 pages. Scopus310 WoS285 Europe PMC208 |
| Year | Citation |
|---|---|
| 2022 | Nsairat, H., Alshaer, W., Mahmoud, I. S., Ismail, M. A., Esawi, E., Alsotari, S., & Ismail, S. I. (2022). Aptamers in Theranostic Bionanomaterials. In Bionanotechnology Next Generation Therapeutic Tools (pp. 130-158). BENTHAM SCIENCE PUBLISHERS. DOI Scopus1 |
| Year | Citation |
|---|---|
| 2025 | Hussein, S. A., Ababneh, N. A., Tarawneh, N., Ismail, M. A., Awidi, A., & Abdalla, S. (2025). Antitumor Effects of Quercetin and Luteolin Are Mediated by Up-Regulation of P-Erk, C-Myc, and the Upstream Gper in A375 Melanoma Cell Line. DOI |
Connect With Me
External Profiles
